Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre
Crossref DOI link: https://doi.org/10.1007/s00392-015-0893-5
Published Online: 2015-07-21
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hoeltzenbein, M.
Beck, E.
Meixner, K.
Schaefer, C.
Kreutz, R.
Text and Data Mining valid from 2015-07-21